|
Sign In to gain access to subscriptions and/or personal tools.
|
A New Graduated Dosing Regimen for Phosphorus Replacement in Patients Receiving Nutrition Support
Kaleb A. Brown, PharmD*, ,
Roland N. Dickerson, PharmD*,
Laurie M. Morgan, RN ,
Kathryn H. Alexander, MS, RD ,
Gayle Minard, MD|| and
Rex O. Brown, PharmD*
From the * Department of Pharmacy, University of
Tennessee Health Science Center, Memphis, Tennessee;
Department of Pharmacy, Methodist
Healthcare–North Hospital, Memphis, Tennessee;
Department of Pharmacy, Regional Medical
Center at Memphis, Memphis, Tennessee;
Department of Food and Nutrition, Regional
Medical Center at Memphis, Memphis, Tennessee; and the||
Department of Surgery, University of Tennessee
Health Science Center, Memphis, Tennessee
Correspondence: Rex O. Brown, PharmD, 847 Monroe Street, Suite 208, University
of Tennessee Health Science Center, Memphis, TN 38163. Electronic mail may be
sent to
rbrown{at}utmem.edu.
Background: Hypophosphatemia is a common metabolic complication in
patients receiving specialized nutrition support. We changed our previously
reported dosing algorithm because the low dose no longer appeared to be
effective at increasing serum phosphorus concentrations. The purpose of this
study was to evaluate the safety and efficacy of a revised weight-based
phosphorus-dosing algorithm in critically ill trauma patients receiving
specialized nutrition support. Methods: Seventy-nine adult trauma
patients with hypophosphatemia (serum phosphorus concentration 0.96
mmol/L) receiving nutrition support received an IV dose of phosphorus on day 1
according to the serum concentration of phosphorus: 0.73–0.96 mmol/L
(0.32 mmol/kg, low dose), 0.51–0.72 mmol/L (0.64 mmol/kg, moderate
dose), and 0.5 mmol/L (1 mmol/kg, high dose). The IV phosphorus bolus dose
was administered at 7.5 mmol/hour. Generally, patients with a serum potassium
concentration <4 mmol/L received potassium phosphate and patients with a
serum potassium concentration 4 mmol/L received sodium phosphate. Patients
who still had hypophosphatemia on day 2 were dosed using the new dosing
algorithm by the nutrition support service according to that day's serum
concentration of phosphorus, or empirically by the trauma service.
Results: Of the 79 patients studied, 57 were male and 22 were female
with a mean age of 44.8 ± 20.6 years. Mean Injury Severity Scores and
APACHE-II scores were 27.1 ± 11.6 and 15.2 ± 6.8, respectively.
There was no difference in baseline characteristics among the 3 dosing groups.
Of the 79 patients, 34 received the low dose, 30 received the moderate dose,
and 15 received the high dose of phosphorous. Mean serum phosphorous
concentrations on day 2 were significantly increased in the moderate-dosed
group (0.64 ± 0.06 to 0.77 ± 0.22 mmol/L, p < .05)
and high-dosed group (0.38 ± 0.06 to 0.93 ± 0.32 mmol/L,
p < .01), respectively, when compared with day 1. Mean serum
phosphorus concentrations were normal in all 3 groups on day 3. Serum
concentrations of magnesium, sodium, and potassium, as well as arterial pH,
were stable across the study. Mean concentrations of ionized calcium were not
significantly different in any of the 3 dosing groups across the study period.
Conclusions: This weight-based phosphorus-dosing algorithm is safe
for use in critically ill patients receiving nutrition support. The
moderateand severe-dose regimens effectively increase serum phosphorus
concentrations.
Journal of Parenteral and Enteral Nutrition, Vol. 30, No. 3,
209-214 (2006)
DOI: 10.1177/0148607106030003209

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. J. Miller
Death Resulting From Overzealous Total Parenteral Nutrition: The Refeeding Syndrome Revisited
Nutr Clin Pract,
April 1, 2008;
23(2):
166 - 171.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|